Real-World Evidence Cases Cases > Real-World Evidence How we’ve helped other companies with registry data Browse the articles below to see how we helped other pharmaceutical companies improve their market positioning with health registry studies. If you’re interested in a different service area, visit our curated collection of cases within Market Access, Advanced Market Research, and Sales Performance. Improving ADHD treatment strategies with real-world data Real-World Evidence Medice Nordic Denmark Resource optimization Inspire me RWE study reveals sustained efficacy of diabetes treatment Real-World Evidence Danish health registries Peer-reviewed findings Inspire me Forecasting trends to drive vaccination uptake in Denmark Real-World Evidence Private market disparities 10 years forecast Inspire me RWD reveals gaps in advanced breast cancer care Real-World Evidence Improved resource planning Better access to care Inspire me Trends in medical treatment for ADHD among Danish incident patients based on real-world data Real-World Evidence Medice Nordic Denmark Patterns differ by sex and age Inspire me Medical adherence to glaucoma treatment Real-World Evidence AbbVie 30k+ patients studied over 10 years Inspire me About Signum Signum empowers life science companies to make data-driven decisions that grow their business and create human impact. Relying on their exclusive access to pharmaceutical sales data and to the Danish Health Data Authority’s Secure Research Platform (“Forskermaskinen”), Signum’s team of 50+ specialists and consultants delivers actionable insights across Real-World Evidence, Market Access, Nordic Market Insights, Sales Performance, and omnichannel HCP engagement. Proudly part of the Lif group (the Danish Association of the Pharmaceutical Industry), Signum has been driving success pre- and post-launch for nearly 50 years. For more information, please contact Anne Cathrine Falch-Jørgensen Head of Nordic Real-World Evidence acfj@signumlifescience.com +45 61 776 975
